DNA methylation is considered a stable epigenetic mark, yet methylation patterns can vary during differentiation and in diseases such as cancer. Local levels of DNA methylation result from opposing enzymatic activities, the rates of which remain largely unknown. Here we developed a theoretical and experimental framework enabling us to infer methylation and demethylation rates at 860,404 CpGs in mouse embryonic stem cells. We find that enzymatic rates can vary as much as two orders of magnitude between CpGs with identical steady-state DNA methylation. Unexpectedly, de novo and maintenance methylation activity is reduced at transcription factor binding sites, while methylation turnover is elevated in transcribed gene bodies. Furthermore, we show that TET activity contributes substantially more than passive demethylation to establishing low methylation levels at distal enhancers. Taken together, our work unveils a genome-scale map of methylation kinetics, revealing highly variable and context-specific activity for the DNA methylation machinery.
DNA methylation is a well-studied epigenetic mark in mammals, where it plays critical roles in the context of genomic imprinting, chromatin architecture, and gene regulation1,2,3,4. While methylation maps in mouse and human cells have provided valuable information regarding the genomic distribution of this mark5,6, they do not reveal the actual dynamics of this DNA modification. This creates a gap in our understanding of not only how methylation patterns are actually achieved, but on their stability, a property required for them to impart long-term epigenetic effects. Indeed, actual activity can only be measured upon acute disruption of one pathway, coupled with time-resolved measurements at high resolution and the appropriate analytical framework.
The methylation machinery can be divided into the de novo methylation enzymes DNMT3a and DNMT3b7,8 and the maintenance methyltransferase DNMT19,10. All members of the Dnmt family are essential for mammalian development8,11. Conversely, DNA methylation can be lost either by incomplete maintenance following replication, referred to as passive demethylation12, or actively via the ten–eleven translocation (TET) family of dioxygenase enzymes13,14,15,16,17. The TET family consists of three proteins in mice, TET1/2/3, with TET2 likely responsible for the majority of hydroxymethylation in embryonic stem cells (ESCs)18. Active demethylation by the TET family is thought to occur through successive oxidation of the methyl group on CpG dinucleotides19,20,21, culminating in excision through the base excision repair pathway13. While absence of distinct members of the TET family is permissible for pluripotency and embryogenesis22,23, reduction in TET activity has been shown to impact differentiation24,25,26. Importantly, loss of all TET enzymes is incompatible with embryogenesis27, indicating a critical role for these proteins in differentiation and lineage specification.
While the division of labor between de novo and maintenance methylation predominantly describes DNMT3 and DNMT1 activities, respectively, evidence exists suggesting this distinction is not absolute. For example, loss of DNMT3a and DNMT3b leads to progressive loss of DNA methylation over many cell passages28. Recent work has also demonstrated that DNMT1 can display de novo activity in oocytes upon UHRF1 mislocalization and loss of Stella29. Regardless, the association of DNMT1 with the replication fork30, the loss of 90% methylation in its absence31, the autoinhibitory function of its CXXC domain32, and much higher preference for hemimethylated substrates33,34 all clearly suggest its predominant function in somatic cells is maintenance.
Previous work has sought to determine methylation activities empirically at CpG sites in vitro35 and in cultured cells34,36, as well as theoretically37,38,39. These studies have revealed several properties of the enzymes responsible for depositing these marks, from presence of non-CpG methylation34,35 to the inference of methylation and maintenance rates for individual CpGs37, as well as DNMT1 processivity38. More recently, these models have been extended and adapted with the aim of describing population methylation dynamics40,41,42. While informative in their own right, their genomic scope is limited or they do not quantitatively infer the rates of all three processes at the individual CpG level, including de novo and maintenance methylation, as well as active demethylation.
Here, we combine acute and stable genetic ablations of methylating and demethylating enzymes with high-coverage quantitative measurements of dynamic DNA methylation over time. Dynamical modeling of the resulting datasets enables us to infer actual rates of methylation and demethylation for individual CpGs at the scale of the genome. Our work not only profiles kinetics of methylation, but also reveals that methylation and demethylation rates are highly context specific, implicating disparate chromatin processes in shaping methylome dynamics in ESCs.
A dynamical model and cellular system to infer turnover rates
DNA methylation is a dynamic process, resulting in the average methylation patterns observed in various cell types. Building on previous conceptual work41,43, these methylation averages result from opposing activities of enzymes that apply and remove DNA methylation (Fig. 1a). Here, we set out to quantify these two activities at the CpG level, namely the rate of methylation (kme) and the rate of demethylation (kde). We define kme as the rate, whereby an unmethylated cytosine (C) is converted to a methylated cytosine (5mC), while kde is the rate at which 5mC is converted to C. Eventually steady state is reached where the number of conversion events in both directions per unit time is equal. These equilibrium methylation levels will henceforth be referred to merely as ‘steady state’ (Fig. 1b). For example, if 50% methylation is measured at steady state, this means that kme and kde are equal. Viewing DNA methylation through this lens provides an explanation for population methylation levels. For example, a 75% methylated cytosine is subject to higher kme than kde, while a 25% methylated cytosine is exactly the opposite (Fig. 1b). However, different rate values can give rise to the same average methylation level, as long as the ratio of the two rates remains unchanged (as shown for 50% methylated cytosines in Fig. 1b). This implies that such methylation dynamics would be masked by simply measuring average methylation levels.
Enzymatically, we attribute kme to the combined activity of the de novo methyltransferases DNMT3a and DNMT3b. In contrast, kde encompasses both active and passive demethylation, governed by the TET1/2/3 proteins and imperfect maintenance by DNMT1, respectively. In presentation of the modeling here, we use kme and kde to outline the processes, while below we will refer to the activities by more general nomenclature, namely as “de novo methylation rate”, “passive demethylation rate”, and “active demethylation rate”. It is important to stress here that “passive demethylation” in this context is synonymous with DNMT1 infidelity. Moreover, we use the term turnover to reflect different absolute rate combinations given an identical steady state. Using the examples of 50% methylated CpGs in Fig. 1b, the CpG on the left would have higher turnover than the CpG on the right. This property can only be revealed by acute pathway disruption coupled with time-resolved measurements (Fig. 1c).
To discriminate between active and passive demethylation processes, we genetically removed all three TET enzymes, leaving DNMT1 fidelity as the sole factor influencing kde (Fig. 1a). Using an existing CRISPR design44, we mutated all six Tet alleles in mouse ESCs, causing frameshifts of the proteins to create catalytically dead enzymes (Supplementary Fig. 1a). This Tet Triple Knockout (TTKO) ESC line proliferates normally as previously shown27 and while it retains 5mC signal, hydroxymethylation is lost as observed by slot blotting with a sensitive 5hmC antibody (Supplementary Fig. 1b).
The knockout of all Tet genes was performed in a particular genetic background that enables inducible removal of de novo methylation. More specifically, we adapted an existing conditional knockout system by breeding mice where catalytic exons for both alleles of Dnmt3a and Dnmt3b are functional, but flanked by loxP sites45,46 (Supplementary Fig. 1c, d). From these mice, we generated a stem cell line homozygous for both alleles to allow genetic deletion by the Cre recombinase (Fig. 1d). While we initially attempted to excise the fragments via inducible Cre activity, this was hindered by premature deletion events due to leaky recombinase activity (data not shown). To circumvent this limitation, we opted for protein transduction, directly adding Cre protein to cells in culture. This system takes advantage of an engineered Cre recombinase that enters the nucleus via a lipophilic tag at the N-terminus47. This proved highly efficient, as nearly 90% of alleles for both enzymes were removed (Supplementary Fig. 1e). While the genotypic proportions of intact alleles will differ between cells, both DNMT3a and DNMT3b signal were undetectable by western blot post Cre transduction (Supplementary Fig. 1f), suggesting most of these functional enzymes were removed. Transcript and most importantly protein levels of DNMT1 and UHRF1 remained comparable upon loss of Tet1/2/3 and Dnmt3a/b, arguing that the maintenance machinery is intact in these genetic backgrounds (Supplemental Fig. 1g, h).
Using the TTKO line, we measured DNA methylation 0, 4, 8, 10, 13, 17, and 29 days post Dnmt3a/3b deletion and focused initially on selected genomic sites with amplicon bisulfite sequencing (Fig. 1e, f, see “Methods”). For this, we assayed 88 genomic regions with disparate steady-state methylation levels, representing TF binding sites, as well as fully methylated regions and promoters (Supplementary Table 1, see GEO submission). Across the time course, methylation levels declined reflecting the absence of de novo methylation activity. Loss of methylation was reproducible (Fig. 1e) and the deep coverage enabled us to analyze 405 CpGs in detail (Supplementary Table 3, see GEO submission and methods for filtering). These data indeed reveal that methylation decays over the time course of the experiment, demonstrating that rate assignments should be possible in this system.
In order to infer de novo methylation and passive demethylation rates from the data, we devised a dynamical model for DNA methylation that mimics the loss of DNMT3 over time (see “Methods” for detailed description). Starting from a framework used previously to describe DNA methylation dynamics43, we modified the rate equation to simulate exponential loss of DNMT3 over the course of the experiment. We achieved this by including an exponential dampening factor for kme with the reasoning that the kme gradually decreases after genetic deletion (Fig. 1g). This is an essential consideration, because Dnmt3 alleles are not deleted instantaneously and protein/RNA are lost as a function of time. This effect can be observed by inspection of the raw data. Instead of following an exponential decay, an attenuation in methylation loss can be seen at the beginning of the time-course experiment (Fig. 1f). The rate of DNMT3 loss is governed by one single parameter ke that we set to reflect various aspects of the cellular system. Given that average protein half-life has a median of 46 h48 and doubling time is 16 h in mESCs49, dilution via cell division is likely the largest contributing factor to DNMT3 loss. If the RNA and Dnmt3 alleles would disappear instantaneously, the DNMT3 loss over time would occur at a maximum rate of log(2)/(16/24) = 1.03, in units of days. Because neither RNA nor genetic loss of Dnmt3 is an instantaneous process, we set ke to half of the theoretical maximum rate. Taken together, we designed a theoretical and experimental system to infer methylation and demethylation rates in the genome that is reproducible and can account for methylation patterns observed in ESCs.
Rate inference reveals the identifiable landscape
Any measure of decay kinetics is limited by detection accuracy and temporal resolution. For example, it is intrinsically more difficult to capture extremely fast kinetics or a decay that starts at very low signal intensity (i.e., low methylation levels). We thus devised a rate inference method that allowed us to both fit rates optimally and determine the confidence at which they can be determined. To this end, we coupled the dynamical model for DNA methylation to a statistical error model (Supplementary Fig. 2a). We then used Bayesian statistics to calculate maximum likelihood estimates, as well as credible intervals for the rates (see “Methods”).
One advantage of this rate inference strategy is that it can provide a complete picture of the assay’s detection limits. For any given combination of kme and kde, we can determine our ability to infer either kme or kde. Applying this to all possible rate combinations resulted in the identifiable landscape (Fig. 2a). Overall, kme is more difficult to infer than kde because the latter is closer to what we are actually measuring. The resulting identifiable landscape revealed a central area of high-confidence parameter estimation (Fig. 2b, case 1), and three areas where rate inference is more difficult (Fig. 2b, cases 2–4). As expected, extreme combinations are hard to retrieve. The most difficult is case 2, representing unmethylated CpGs (high kde and low kme). These CpGs are unmethylated throughout the time course and thus provide no information. Additionally, 50% methylated cytosines with very low rates would be difficult to infer (Fig. 2b, case 3), as very little decay is observed throughout the time-course coupled with the higher variability in measuring 50% methylated cytosines. Perhaps least intuitively, in the case of highly methylated cytosines, only kme was difficult to infer (Fig. 2b, case 4). While decay (kde) is easily quantifiable at high methylation levels, hitting the methylation ceiling close to 100% prohibits the exact inference of kme.
Many of the cytosines covered in our amplicon dataset revealed rate combinations that we could infer with high confidence (Fig. 2c, blue points). Indeed, many of the problematic inference zones were not represented. For example, CpGs with a steady-state methylation level of 50% but very low turnover (bottom left corner of Fig. 2c, i.e., very low rates) were rare. It is important to note that while these rate combinations are inferred with lower confidence, they still would be detectable within these regions, as can be seen for CpGs with very low steady-state methylation levels (Fig. 2c, bottom right red and black points). Taken as a whole, our inference method is capable of accurately discriminating regimes where rates can be inferred, and the majority of the cytosines we profiled reside in high-confidence regions.
Rate inference at the genomic scale
At first glance, determining methylation and demethylation rates at the genomic scale appears straightforward, as it requires bisulfite sequencing of all samples for the time-course experiment. However, the deep coverage required for proper rate assignments (minimum of 50× coverage for 24 samples) makes this cost prohibitive unless genome complexity is substantially reduced. To accomplish this, we used the SureSelect system that employs RNA baits homologous to 297,000 genomic regions (Fig. 3a, see “Methods”), predesigned to enrich for regulatory regions and disease relevant loci. This enrichment was apparent when inspecting raw reads (Fig. 3a) and we confirmed the observation at the global level, with nearly 90% of all mapped reads localizing within 200 bp of bait regions (Fig. 3b). In total, this resulted in a mean of 234 million reads mapped per library, sufficient coverage for high-confidence rate inference at 860,406 CpGs, representing 151k unique genomic locations (~51% of SureSelect baits) and ~4% of CpGs in the mouse genome (Supplementary Table 4, see GEO submission).
Methylation levels decayed steadily over time after Dnmt3 deletion (Supplementary Fig. 3a). Variance in methylation measurements could be predominantly explained by random sampling of reads from a binomial distribution, whereby variance in methylation levels for cytosines scaled with coverage as expected from random sampling50 (Supplementary Fig. 3b). Patterns of methylation across CpGs measured at the given sampling time points were highly reproducible across replicates with clustering driven predominantly by the time point analyzed (Fig. 3c). Additionally, for CpGs quantified using both amplicon sequencing and SureSelect (259 of 405), methylation levels were well correlated (R = 0.98, Supplementary Fig. 3c). Demethylation rates for ~40% of the cytosines could be assigned with high confidence (860k of 2.1 × 106), revealing that passive demethylation rates vary widely. On average demethylation rates show an interquartile range of 1.7 fold, but CpG demethylation rates can vary up to 158 fold, exposing that CpGs sharing the same steady-state methylation levels can have highly different kinetics of methylation loss (Fig. 3d, right). Importantly, while a significant proportion of the probe design represents active regulatory elements, ~40% of regions we assay with SureSelect lack DHS signal in ESCs (Supplementary Fig. 3d). Thus, CpGs are represented in active regulatory regions, as well as inaccessible intergenic domains. In summary, we reproducibly inferred rates of methylation and demethylation for nearly 1 million CpGs in mouse ESCs. By observing different kinetics for shared steady states, our data uncover the dynamic aspect of the methylome normally masked in steady-state measurements.
Rate combinations reveal context-specific activity
Having extended our rate inference to the genomic level, we first interrogated the relationship between rates of de novo methylation and passive demethylation (Fig. 4a). The relationship between these rates is complex, suggesting that genomic context can have different implications for de novo and maintenance methylation. As a reference, steady-state methylation levels are depicted in Fig. 4a by 45° lines, as the ratio between rates is constant along each line.
Upon closer inspection of the rate relationship, two particular patterns emerge. First, CpGs with a steady-state methylation above 70% vary greatly in turnover (Fig. 4a, upper arm, points in the upper left above the 70% methylation line). This suggests a positive relationship between de novo methylation rate and passive demethylation at highly methylated CpGs (see below). Second, CpGs with average methylation below 50% have elevated passive demethylation coupled with variable de novo methylation rates (Fig. 4a, lower arm, points to the lower right of the 50% methylation line). This suggests that low methylation levels observed in genomic methylation maps are a result of both an increase in passive demethylation, as well as a reduction in de novo methylation. Importantly, these relationships remain when accounting for inference confidence levels (Supplementary Fig. 4a). Additionally, regions with higher turnover tended to reside in earlier replicating regions of the genome (Supplementary Fig. 4b) in agreement with their euchromatic context51.
Next, we asked if these local differences in enzymatic activities could reflect other features of the epigenome. Using a published classifier52,53 of chromatin states in mouse ESCs53,54, we assigned each CpG to a particular genomic context defined by TF occupancy and combinations of histone modifications (Fig. 4b). This revealed that particular genomic environments overlapped with specific rate regimes. For example, CpGs outside of genes and regulatory regions (H3K9me3+) show high steady-state methylation, yet surprisingly variable rate combinations. While also highly methylated, CpGs residing in active gene bodies (H3K36me3+) show higher turnover. In contrast, highly methylated intergenic CpGs tend to have reduced passive demethylation and de novo methylation rates, revealing higher DNMT1 fidelity at these regions coupled with reduced DNMT3 activity.
CpGs within active regulatory elements and at insulator regions (CTCF+), in contrast, have reduced overall methylation levels as shown previously5, but reveal an intriguing relationship in regards to total activity. Passive demethylation is elevated indicating reduced maintenance by DNMT1 at active regulatory elements, including strong enhancers (NANOG+, OCT4+, H3K27Ac+, H3K9Ac+, and H3K4me1/3+). At the same time, de novo methylation activity varies widely in these regions, potentially indicating that transacting factors present at specific regulatory regions may affect DNMT3 activity differently (see below). While many promoter CpGs (H3K4me3+, H3K27Ac+, and H3K9Ac+) are also present in this regime, their rates cannot be determined with high confidence as their steady-state methylation levels are too low to allow for robust kinetic analysis (Supplementary Fig. 4a). In summary, our results reveal that methylated cytosines have both highly variable methylation kinetics and a surprising abundance of sites with high rates of passive demethylation that is normally masked by de novo methylation activity.
Site specificity of active demethylation by the TET enzymes
Having quantified passive demethylation at the genome scale, we sought to determine the contribution of TET-dependent, “active” demethylation at these CpGs. More specifically, we sought to interrogate how TET proteins affect demethylation rates at the CpGs we measured previously. Our model framework would predict that we can determine the change in demethylation rates by comparing steady-state methylation levels between ESCs with and without TET proteins (Supplementary Fig. 4c). We therefore measured methylation levels at these CpGs in the presence of TET1/2/3 and observed an almost unidirectional increase in methylation levels when TET proteins are absent (Fig. 4c). This observation is indeed in agreement with the defined role of TETs as demethylases, and our model assignment of these proteins as demethylases. In this context, we refer to the contribution of TETs to the demethylation rate as TET activity. More specifically, this number represents the fold change in kde when TETs are present (in log2 space). To validate rate predictions in an independent manner, we performed amplicon bisulfite time-course experiments following Dnmt3 deletion in the parental cell line with TET activity (Supplementary Table 2). As expected, kde values determined by the time course showed very high correlation (R = 0.88) to those predicted using only changes in steady-state methylation (see Supplementary Fig. 4c–h and “Methods”), representing a strong validation of our modeling strategy.
The presence of TET activity drastically affected demethylation rates throughout the genome, increasing them at least threefold for half of all CpGs analyzed (~476,895 CpGs, Fig. 4c inset). This effect is most apparent at enhancer elements, followed by polycomb marked regions and gene bodies (Fig. 4d). Taken together, this revealed that TET proteins have a considerable influence on the demethylation rate. This contribution in ESCs tends to be greater than DNMT1 infidelity and is highest at active distal regulatory elements.
Next, we asked whether active and passive demethylation scale in a similar fashion. While TET activity is highest in regions with elevated passive demethylation (Supplementary Fig. 4i), the relationship is complex, as rates of passive and active demethylation vary widely between individual CpGs (Supplementary Fig. 4j). While TET activity reaches its maximum in active regulatory elements and bivalent domains, regions with the highest levels of passive demethylation reveal little TET activity. Several of these CpGs indeed overlap closely with TF binding sites as can be seen for CTCF (Fig. 4b, Supplementary Fig. 4i, j), suggesting that continuous presence of TFs inhibits both TET and DNMT1 activity directly at the site of binding. In contrast, heterochromatic intergenic regions generally have both low active and passive demethylation. We conclude that CpGs reside in different rate regimes as a function of genomic context, and TET activity has an overall effect of increasing demethylation rates throughout the genome, but particularly at enhancers.
Transcription correlates with methylation turnover
CpGs with particularly high steady-state methylation levels (≥70%) displayed a remarkable linear relationship between de novo methylation and passive demethylation rates (Fig. 5a, red points). We reasoned that CpGs with high steady-state methylation but different rates of turnover might be residing in regions of different transcriptional activity (Fig. 4b). To address this, we grouped genes based on their transcriptional output and tallied steady-state methylation, de novo methylation rate, and active/passive demethylation rate as a function of relative position in the gene (Fig. 5b, Supplementary Fig. 5a). This revealed that total methylation turnover increases with transcriptional activity and in turn argues that the high overall methylation observed at genes is in constant flux as a function of transcription. This is also evident for individual rates as methylation by DNMT3 increases with transcriptional output (Fig. 5b). Recruitment of de novo activity in genes likely involves H3 methylation at lysine 36. The presence of this modification increases with transcriptional rate and it is recognized by DNMT3b55, which has been suggested to be functionally required for genic methylation56.
The requirement for continuous de novo methylation may arise due to higher demethylation rates at transcribed genes. In addition to de novo methylation rate, both active and passive demethylation increase in gene bodies with transcriptional output, although to a lesser degree. Importantly, however, measured turnover rates are largely independent of whether CpGs reside in introns or exons (Supplementary Fig. 5b). Furthermore, this signal is unlikely to result from increased accessibility in transcribed gene bodies, as we do not observe a higher prevalence of DNAseI hypersensitive sites in highly transcribed gene bodies (Supplementary Fig. 5c). However, we do observe increased histone turnover as revealed by H3.3 ChIP signal57 (Supplementary Fig. 5c). This links transcription coupled deposition of replication-independent histones58 with reduced DNMT1 fidelity. In summary, transcription coincides with high turnover of DNA methylation at genic regions.
Heterochromatin and euchromatin show opposing turnover rates
CpGs with high steady-state methylation but variable turnover also exist outside of genic regions, allowing us to explore their relationship with other chromatin marks. This revealed that CpGs with high methylation but low turnover were progressively enriched for the heterochromatic marks H3K9me2 and H3K9me3 (Fig. 5c, Supplementary Fig. 5d, e). This positive correlation between DNMT1 fidelity and presence of H3K9 methylation marks is in line with the known interaction of methylated H3K9 with UHRF159, an accessory factor required for maintenance methylation60,61.
Interestingly, a subset of highly methylated cytosines display both high turnover and low H3K36me3. As these CpGs overlap with regions of local enrichment for H3K4me1 and H3K27ac (Fig. 5c), we reasoned that these particular CpGs might be positioned proximal to active regulatory regions despite being hypermethylated. Indeed this is the case (Fig. 5d), as CpGs that border regulatory regions are under a regime of elevated methylation turnover. It has been shown previously that CpGs residing in the proximity of CpG island shores can exhibit variable methylation levels62,63. Our data now argue that these CpGs are under a regime of higher turnover even in a cell state, where they are highly methylated. We conclude that hypermethylated CpGs can undergo high methylation turnover, when proximal to regulatory regions or positioned within highly active genes.
Transcription factor-specific effects on methylation kinetics
Transcription factor binding coincides with reduced DNA methylation levels observed at regulatory regions, such as enhancers and CpG islands5. To ask how methylation turnover relates to TF presence, we used DNAseI accessibility as a surrogate for TF binding. This revealed that de novo methylation globally decreases with increased accessibility, while both active and passive demethylation increase (Fig. 6a). This shift in rates readily explains the established low methylation levels at cis-acting sequences and supports a model where TF binding to regulatory regions reduces DNMT1 and DNMT3 activity, while increasing that of TETs.
To determine if this effect is transcription factor specific, we used publicly available genome-wide binding data for 15 TFs in mouse ESCs and visualized methylation turnover as a function of proximity to bound distal motifs (see “Methods” for ChIP data processing). For several factors, including CTCF, ZC3H11A, and REST, the general reduction in maintenance and de novo methylation was readily apparent surrounding bound sites (Fig. 6b). However, while de novo and maintenance methylation are generally reduced in the vicinity of binding for all factors, discrete patterns were much less apparent for the other 12 TFs. This heterogeneity is likely caused by co-occupancy, particularly in the case of pluripotency factors64. In contrast, the unique chromatin structure of both CTCF65,66 and REST66 bound sites may enhance rate signatures at bound regions (see below). Of note, TCFCP2I1 and ESRRB both show subtle patterns of an opposite effect, namely increased de novo and maintenance methylation rates at their motifs (Supplementary Fig. 6b, c). Importantly, this effect is present at sites of binding that are not hypersensitive to DNAseI digestion, suggesting that it is less likely a result of adjacent bound factors. In the case of ESRRB, increased de novo methylation at bound sites seems compatible with the observation that it can bind to methylated enhancers67,68.
Active demethylation on the other hand followed a more general consensus, namely highest levels of TET activity adjacent to bound sites (Fig. 6b, right). This was evident for all 15 transcription factors analyzed, with OCT4, SOX2, and NANOG revealing up to a 16-fold increase in demethylation rate as a function of TET activity. As the 15 TFs profiled represent members from distinct families, this might indicate that TET proteins are less likely to be specifically targeted through direct interaction, but rather through preferable binding to open chromatin. Indeed TET activity generally increases with increasing accessibility, as suggested by its contribution to the demethylation rate adjacent to bound motifs at distal sites (Fig. 6a right, Fig. 6c). We then reasoned that if these patterns result from TF presence, signal strength should increase as a function of binding. For several factors, including CTCF, ZH3H11A, OCT4, and NANOG, the patterning of rates became more striking with increased ChIP signal (Supplementary Fig. 6a). De novo methylation rates tend to decrease, passive demethylation increases, while active demethylation increases (OCT4 and NANOG) or becomes specifically localized adjacent to the TF in question or in linkers between nucleosomes.
We conclude that regulatory regions show a reduction in de novo and maintenance methylation, and increase in active demethylation as the most prominent pattern. While this is a function of TF binding, some factors reveal different trends suggesting TF-specific influence on these rates.
Nucleosome occupancy contributes to local turnover
Having interrogated rates as a function of TF binding, we next asked how methylation turnover changes at highly positioned nucleosomes. In the case of the insulator protein CTCF, bound sites show reduced DNMT1 fidelity and DNMT3 activity compatible with a model of steric hindrance, where TF binding impedes both de novo and maintenance methylation activities (Fig. 6c). Importantly, the region of enhanced passive demethylation included not only the binding site itself, but extended ~250 bp on both sides of the binding site. We reasoned this may be due to highly positioned nucleosomes adjacent to the bound factor. Indeed, using a high-coverage MNase data set that we generated previously69, highly phased nucleosomes around CTCF sites closely overlap with the region of increased passive demethylation and decreased de novo methylation (Fig. 6c, Supplementary Fig. 6d). Indeed, this pattern includes nucleosomes bordering the binding site and extends until the linker between the first and second nucleosome is reached. These observations suggest that both CTCF binding and bordering nucleosomes reduce DNMT activity. Active demethylation, in contrast, is very low at the motif itself but increases directly adjacent to it and subsequently decreases over the bordering nucleosomes in a fashion similar to DNMT3. Also apparent is that both active demethylation and de novo methylation increase in linkers between nucleosomes and immediately adjacent to CTCF. Taken together, our findings suggest that both factor binding and positioned nucleosomes inhibit DNMT1 and DNMT3, while accessibility is a strong determinant for active demethylation (Fig. 6d). These activities, in turn, likely account for the complex and cell type-specific patterns of reduced methylation levels observed at regulatory regions.
Here, we established a theoretical and experimental framework to quantify local methylation and demethylation activity at single-CpG resolution throughout the genome of mouse ESCs. Studying methylation as a continuous process reveals that methylation levels do not predict methylation turnover, which can differ over two orders of magnitude. This finding was made possible by generating inducible deletions of both de novo methyltransferases in a cellular background, where we removed all three TET enzymes. Quantification of the methylation kinetics in this Penta-knockout over time at high coverage enabled us to infer actual rates of activity at individual CpGs. It revealed that de novo methylation, as well as passive and active demethylation activities are affected by local variations in chromatin, transcriptional activity, and TF binding, leading to complex rate patterns that readily explain steady-state methylation levels.
Our study builds on and extends previous conceptual and empirical attempts34,37,38 at quantifying methylation activity in different genomic contexts. However, our approach distinguishes itself in several aspects. First, fitting rate combinations using the dynamical model coupled to an error model as a framework to infer activity is, to our knowledge, the first of its kind. One major advantage of this modeling approach is that it allows us to resolve which rate combinations can be inferred in this system. While the inability to fit rates for CpGs at exceedingly low methylation levels is obvious, fitting rates for very highly methylated cytosines can also be problematic. Intermediately methylated CpGs with low rates are likewise difficult to infer, due in large part to the variance in methylation measurements for CpGs approaching 50% steady state. Second, we have determined rates with high confidence at just under 1 million CpGs across the genome enabling high resolution and comprehensive analysis of methylation kinetics.
The rate patterns for de novo methylation we observe are fully compatible with the described inhibition of DNMT3 by histone H3 methylated at lysine 470,71. This could at least in part explain reduced activity of DNMT3 at active promoters and enhancers. Additionally, the increase in de novo methylation rates in highly transcribed gene bodies supports previous findings regarding DNMT3 affinity to H3K36 methylation55,72, a mark that occurs at transcribed genes and scales with transcription through association with elongating RNA polymerase73,74. This de novo activity is required to keep these sequences methylated as it coincides with reduced DNMT1 maintenance and increased TET activity, leading to elevated turnover that scales with transcription rate. Our observation that H3.3 signal scales in a similar manner link histone turnover with reduced DNMT1 fidelity and increased TET activity. Nevertheless, targeted gene body methylation is both ancient, spanning 900 million years of metazoan evolution75,76, and poorly understood. Several hypothesis have been put forth77,78, including gene silencing in plants79, suppression of spurious transcription start sites56, or a mere byproduct of transposon silencing76. While the function of gene body methylation remains mysterious, our observation of increased turnover of methylation in these regions coupled with conservation further argues for a functional role.
Methylation kinetics of highly methylated intergenic CpGs represent another intriguing case. At the global scale, CpGs in this context seem to underlie two regimes. First, CpGs distal from active regulatory elements reside in neighborhoods of increasing H3K9me2/3 and high fidelity of DNMT1. This is in agreement with the observation that the cofactor Uhrf1 recognizes this mark80,81,82,83, and is involved in maintenance activity of DNMT160,61. The second regime represents CpGs increasingly closer to active regulatory elements, which show high turnover driven by both active and passive demethylation. It is tempting to speculate that these methylation dynamics create binding opportunities for methylation sensitive transcription factors84,85,86.
Time-course measurements in the presence and absence of TET proteins allowed us to distinguish between active and passive demethylation. One surprising result is the reduced fidelity of DNMT1 around distal regulatory regions (see below). Global demethylation had been initially observed in long-term cultures of DNMT3 knockout stem cell lines28. While this loss was attributed to DNMT1 infidelity, it is important to note that TETs were present in these cells, but had not been discovered at the time this study was published. Indeed, we show that TET proteins have a significant effect on demethylation rates at hundreds of thousands of CpGs scattered across the genome, and that TET activity has a stronger effect on the demethylation rate than DNMT1 infidelity. It is important to note that we cannot distinguish whether the effect of TET activity on demethylation rate is due to bona fide active demethylation (base excision), or incomplete maintenance of oxidized methyl groups87.
Complete loss of TET activity caused an almost unimodal increase in steady-state methylation, which is partially at odds with previous findings in TET mutants where hyper- and hypomethylated regions were more evenly represented18,88. While this discrepancy could in part be due to our enrichment of active regulatory elements, approximately half of the bait regions in our study do not overlap with DHS signal. Our observation of a nearly exclusive hypermethylation phenotype is in support of a role for this protein in increasing the demethylation rate, as we have assigned in our model. While the effect of reduced methylation by TET enzymes on gene regulation is not completely understood, TET function has been implicated in activation of differentiation specific genes18. Our observation that TET activity is generally enhanced at bound TF sites raises the intriguing possibility that the permissive chromatin environment afforded by TF binding can help to create regions of local hypomethylation89,90,91,92. In turn, this local hypomethylation could create an opportunity for the binding of additional TFs. Moreover, the scaling of multiply oxidized bases with local chromatin accessibility has been previously documented93, and thus we speculate that TET activity is less likely caused by specific recruitment but rather accessibility caused by factor binding. While we cannot rule out the possibility of recruitment as has been documented for selected factors94,95,96,97, our data are more in support of the simple scenario where TET proteins have higher activity at accessible regions. Our data further argue that TF binding inhibits both DNMT3 and DNMT1 activity, producing unmethylated cytosines that can be recognized by the CXXC domains of TET proteins. Local recruitment of TET proteins could then serve to increase TET activity on neighboring methylated cytosines. In the case of TET1 and TET3, this interaction can be facilitated directly by their CXXC domains98,99,100, and in the case of TET2 possibly through its interaction with IDAX101. The preference for TET activity at accessible sites is further supported by our observation of increased activity in linker regions of positioned nucleosomes, with decreasing activity over the nucleosome itself.
Indeed, using ChIP-Seq data from 15 transcription factors, we find that maximum TET activity is localized in the immediate vicinity of transcription factor bound sites, where higher accessibility is expected. This seems to be partially independent of steady-state methylation levels, as high turnover is also prevalent at CpGs with high steady-state methylation levels nearby and flanking DHS sites. We interpret this to be the net result of increased DNMT1 infidelity, de novo methylation rate, and TET activity. The net result is a CpG site with higher methylation levels and elevated turnover, and these CpGs tend to occupy the borders of regulatory elements.
CpGs located at active regulatory regions reveal highly variable kinetics. One of the most striking is the elevated maintenance error coupled with the more variable rate of de novo activity. Both these observations fit a model whereby steric hindrance results in reduced methylation (Fig. 6d). Indeed, it has been shown that active regulatory elements reveal slower kinetics of remethylation after passage of the replication fork102. These results are compatible with a model, where many DNA binding factors rebind their consensus motifs quickly after replication and in turn interfere with the maintenance methylation reaction.
Similarly, factor occupancy in other phases of the cell cycle could inhibit de novo methylation activity. Reduction in de novo activity and maintenance fidelity increase with local accessibility, and taken together contribute to low steady-state methylation levels observed at regulatory regions. This scenario creates ample molecular opportunities for TFs to create a region of reduced methylation as we have shown previously for REST5, which could enable binding of DNA methylation sensitive TFs, such as Nrf1 103. Surprisingly, although several of the 15 tested TFs seem to cause reduced methylation, there are notable exceptions. For example, ESRRB and TCFCP2l1 sites show a slightly different pattern of rates at distal bound sites with low DHS signal, namely an increase in both de novo and maintenance activity. Both factors are specific to ESCs and may serve as early binding proteins in the hierarchy of pluripotency factor enhancer binding67.
Taken together our combination of theoretical and experimental work reveals a significant layer of information previously unresolved by methylome profiling. It exposes this part of the epigenome as a highly dynamic entity within particular genomic contexts.
Cell line generation
ESC lines conditionally deficient for Dnmt3a and Dnmt3b were derived by outgrowth of blastocyst embryos obtained by crossing mice doubly homozygous for floxed alleles of Dnmt3a and Dnmt3b46. The mouse strain was maintained on a C57BL6/J background. Mice were genotyped by PCR and ESCs derived from a homozygous clone. The Dnmt3a/3b flox/flox line was passaged on feeder cells. TET TKO cells were generated from this line using a previously described protocol44. In short, guides directed at the catalytic exons of the TET enzymes were cloned into the pX330 vector and all three were cotransfected into the Dnmt3a/3b flox/flox cell line. DNA was extracted from individually picked clones and PCR product amplified overlapping the CRISPR cut site. The PCR fragment from clones was then treated with a restriction enzyme whose recognition sequence is close to the cut site, thus undigested fragments would represent mutated alleles. Alleles were sequenced from one clone displaying likely mutations in all six alleles (Supplementary Fig. 1).
Slot blotting of putative TTKO clones was carried out following an established protocol104, using an antibody against 5hmC (#39769, Active Motif) and 5mC (BI-MECY-1000, Eurogentec). Genomic DNA was denatured with 4 N NaOH and the solution was neutralized by addition of an equal volume of 2.5 M ice-cold NH4Ac. The single-stranded DNA was spotted on a TE-soaked nylon membrane and then baked at 80 °C for 30 min and UV cross-linked.
ESCs were cultured on feeders105 and passaged at least once on feeders prior to trypsinization for Cre protein transduction. For transduction106, ESCs were trypsinized, resuspended in PBS and quantified. Approximately 2.5 × 105 cells were transferred into fresh falcon tubes, spun down, and resuspended in 500 μl of filtered serum-free medium containing either 1 μM Cre protein or an equivalent volume of Cre dialysis buffer (2 M NaCl, 50 mM HEPES pH7.4, 1 mM DTT, 1 mM EDTA, and 5% Glycerol). The cells were then plated in 24-well plates precoated with feeders (2–48 h in advance) and prewashed twice with PBS. After 16 h, cells were washed twice with PBS and coated with FCS-based ES medium105. ESCs were transferred to gelatin-coated feeder-free six-well plates 24 h and to 10 cm plates 72 h after transduction. Pellets were collected from trypsinized cells at indicated time points and culturing was continued until 29 days post transduction in a feeder-free environment. All ESCs used for Cre transduction experiments were cultured for at least ten passages prior to Cre transduction.
Genomic DNA was extracted by resuspending cells in 1% SDS with 50 µg proteinase K and incubation at 55° for 5 h. The cell lysate was then mixed at a 1:1 ratio with a mix of phenol:chloroform, spun at max speed for 5 min, and the upper aqueous layer was retained. A second phenol:chloroform extraction was performed, and subsequently chloroform was added at a 1:1 ratio, mixed, and spun for 5 min at RT at 12,000 × g. The upper phase was retained and DNA precipitated by adjusting the aqueous phase to 300 mM NaOAc and >70% ethanol followed by centrifugation at 12,000 × g at 4 °C. The DNA pellet was washed with 70% ethanol, dried, and resuspended in 10 mM Tris pH 8.0. DNA was treated with 50 µg/ml RNase and precipitated using 300 mM NaOAc and >70% ethanol as above.
Primers and probes were designed complementary to sequences between the loxP sites for Dnmt3a and Dnmt3b (see Supplementary Fig. 1 for sequences). For the reaction, 30 ng of genomic DNA, 900 nM of primers, and 0.25 nM of probe were mixed with 1× TaqMan Universal PCR master mix in a total volume of 25 µl. Cycling conditions were an original incubation of 2 min at 50° followed by 10 min at 95°, and then 40 cycles of 15 s at 95° and extension for 1 min at 60°. Primers and a probe were designed for Gapdh to use for normalization, and relative allele frequency was calculated using a previously described method107. For comparative purposes, DNA from Dnmt3a/Dnmt3b knockout cells was mixed with wild-type ESC DNA at ratios of 100:0, 30:0, and 0:100, respectively.
Whole cell lysate was extracted by resuspending ~1 × 106 cells in 100 µl RIPA buffer (50 mM Tris pH 8.0, 150 mM NaCl, 1% NP-40, 0.5% sodium deoxycholate, and 0.1% SDS) followed by incubation for 30 min at 4 °C. Samples were then sonicated for six cycles of 30 s on, 30 min off on the Diagenode Bioruptor and subsequently spun for 20 min at 10,000 × g while cooled to 4 °C. The supernatant was retained, diluted 50× and quantified using the Micro BCA Protein Assay Kit from Pierce. Approximately 20 µg of protein was separated using a Thermo Fisher NuPage 3–8% tris-acetate gel and transferred onto an activated PVDF membrane. The membrane was blocked for 1 h at room temperature in 5% milk resuspended in TBST (10 mM Tris, 1.5 M NaCl, and 1% Tween-20). Antibodies for DNMT3A (Novus 64B1446, 1:1000), DNMT3B (Imgenex IMG-184A, 1:1000), DNMT1 (AbCam ab188453), UHRF1 (MBL D289-3), or LAMIN B1 (AbCam ab16048, 1:10,000) were diluted in 5% milk in TBST and incubated on the membrane overnight at 4 °C with rotation. Membranes were washed four times for 4 min in TBST, and incubated with HRP-conjugated secondary antibodies (GE RPN4201V for DNMT3A and DNMT3B, GE NA934V for LAMIN B1 and DNMT1, Sigma AP136P for UHRF1, 1:10,000 dilution for all) for 1 h at RT. Membranes were washed four times for 4 min in TBST, incubated for 2 min with Advansta WesternBright Sirius chemiluminescent substrate and acquired on the GE Amersham Imager 680. All signals in Supplementary Fig. 1f are from the same membrane. The membrane was stripped after each individual blot by incubating the membrane for 15 min in Thermo Scientific Restore Western Stripping Buffer (#21059), washed three times for 4 min in TBST followed by blocking and incubation of primary antibodies as described above.
Amplicon bisulfite sequencing
Approximately 2 µg of extracted genomic DNA from days 0, 4, 8, 10, 13, 17, and 29 were first mixed with 3.2 pg of both unmethylated Lambda bacteriophage and in vitro methylated T7 bacteriophage DNA. Addition of the bacteriophage DNA was used to control for bisulfite conversion efficiency. Samples were then bisulfite converted using the EpiTect kit from Qiagen per the manufacturer’s instructions. Primers designed to amplify UMRs, LMR, and FMR regions (88 in total, Supplementary Table 1, see GEO submission) were distributed in 96-well plates and amplification was carried out using Amplitaq gold and the following thermocycler settings (all temperatures are in Celsius and all incubation times are 30 s unless specified): 1 cycle of 95° for 9 min, 20 cycles of touchdown with 95° melt, 55°–51° annealing, and extension at 72°, followed by 36 cycles of 95° melt, 51° annealing, and 72° extension.
The amplicon reactions were then mixed, run out on an agarose gel, and DNA extracted. Libraries were then constructed using the NEBNext ChIP-seq Library Prep kit (#E6240) as per the manufacturer’s instructions, indexed, pooled, and sequenced using the Illumina MiSeq platform in 250 bp paired-end mode. The last 100 base pairs were trimmed due to reduced sequencing quality, and aligned to the mm9 build using Rbowtie in the QuasR package and the following parameters: genome = “BSgenome.Mmusculus.UCSC.mm9”, paired = “fr”, and bisulfite = “undir”.
SureSelect enrichment and subsequent sequencing of bisulfite DNA was carried out as per the manufacturer’s instructions. Briefly, genomic DNA isolated from the time points above was sonicated down to 150–200 base pairs in size using a Covaris S220, followed by library construction. The libraries were then hybridized to probes (Mouse Methyl-Seq XT, 931052), bound to streptavidin beads, washed, and bisulfite converted using the EZ DNA methylation Gold kit from Zymo (D5005). Bisulfite-converted DNA libraries were then amplified and indexed, pooled and sequenced in 51 bp paired-end mode using the Illumina HiSeq platform. Sequenced reads were aligned to the mm9 build using Rbowtie in the QuasR environment with the following parameters: genome = “BSgenome.Mmusculus.UCSC.mm9”, bisulfite = “dir”, aligner = “Rbowtie”, and paired = ‘fr’. Methylation levels were determined using the qMeth function from the QuasR package.
Amplicon and SureSelect bisulfite data processing
Methylation levels for CpGs in amplicons was determined using the AmpliconViews function from the R package AmpliconBiSeq108 with the parameters ‘conv = 80’ and exp.var = ‘90’. A minimum of 100× coverage was required for all methylation calls. If coverage did not reach this threshold for any time point, the respective methylation level was set to NA. We further removed all CpGs with NA at day 0 or with more than one NA during the time course across all replicates. In addition, we filtered out one amplicon (chr7:149767665-149767784) containing nine CpGs due to high variability in methylation calls. From a total of 588 CpGs initially quantified, this filtering procedure resulted in 405 CpGs. For SureSelect, a minimum of 50× coverage in all time points and replicates was used to filter CpGs for further analysis.
A dynamical model for DNA methylation
To enable inference of methylation and demethylation rates from the time-course data, we conceived a dynamical model for DNA methylation. This model is framed in the context of a simple chemical reaction with two rates: unmethylated cytosines are converted to methylated cytosines at a de novo methylation rate (kme), while methylated cytosines are converted to unmethylated cytosines at a demethylation rate (kde). This system can be described by two differential equations (DGLs) and further simplified into a single DGL (Fig. 1a). To simulate the loss of DNMT3 over time, we modified the DGL to gradually reduce the kme over the course of the experiment through an exponential dampening factor exp(−kE). We set kE to a value of 0.5 considering various aspects of the experimental system. More specifically, we first assumed that the loss of methylation maintenance is considerably greater than de novo methylation. On a conceptual level, methylation levels will decrease 50% every cell cycle if maintenance is completely disrupted. Given a doubling time of 16 h, this would correspond to a rate of log(2)/(16/24) = 1.04. Because both loss of RNA and protein is not instantaneous, we set the value of kE to 0.5.
As complete loss of maintenance is probably the most extreme case, the rates under investigation in this study are expected to be substantially <1.04. Nevertheless, to include more extreme cases we still considered rates of up to two and discretized kde and kme at steps of 10%, covering a dynamic range of three orders of magnitude across 80 steps. This resulted in a total of 6400 parameter combinations for kde and kme. We next used a brute force approach to solve the DGL numerically for all possible parameter combinations using the R package deSolve109. Initial conditions were set such that the methylation levels at time = 0 were equivalent to the respective steady-state levels given the rates of methylation and demethylation (Meq = kme /(kde + kme)).
Having generated the 6400 methylation traces, we added two types of errors to take into account further aspects of the system not covered by the DGL. For example, our genotyping data for DNMT3 loss showed that the genetic excision was not complete, retaining on average 8% of functional DNMT3 alleles. We simulated incomplete excision by mixing 8% of the methylation levels observed at day 0 with 92% of the simulated time course. Finally, we also considered bisulfite conversion and sequencing errors by assuming 99.75% efficiency and injected those effects into the simulated methylation traces using the formula y = (1 − 0.0025 − 0.0025) × x + 0.0025. In summary, for all 6400 parameter combinations, this procedure produced 6400 methylation traces that we compared to real time-course data in order to infer rates of methylation and demethylation.
Inference of amplicon methylation/demethylation rates
To infer methylation/demethylation rates as well as confidence values for those rates, we coupled the dynamical DNA methylation model (which mimics the loss of DNMT3a/b over time) to a statistical error model. We chose to use a reparameterized beta-binomial error model that was successfully applied to bisulfite data in the past110. In contrast to the binomial distribution B(n,p) that is governed by the two parameters n (number of trails) and p (success probability), the beta-binomial distribution BB(n,p,γ) has one additional parameter γ to account for over-dispersion. Over-dispersion is critical in the case of the amplicon data due to an average of 4000× coverage per CpG. Given this depth of coverage, the theoretical error predicted by the binomial distribution would be much smaller than the actual error observed between replicate experiments. We determined biological variation by calculating the standard deviations of methylation levels observed in replicate experiments (at day 0) as a function of read coverage. Additionally, we stratified the data by mean methylation level because noise in bisulfite data is also a function of the mean. This showed that the beta-binomial distribution performed well in capturing the error observed in the amplicon bisulfite data (Supplementary Fig. 2c). To determine the optimal value for γ, we performed a parameter sweep, calculating the sum of squared errors to the actual data and selecting the minimum (γ = 0.0055; Supplementary Fig. 2b). Coupling this error model to the dynamical model for DNA methylation allowed us to use a statistical framework to obtain uncertainties for the inferred parameters. For a given combination of the two parameters kde and kme, we calculated the probability of the data given the parameters p(data|parameters) using the respective simulated trace to set the parameter p in the beta-binomial distribution and the read coverage to set the parameter n. To obtain a single probability for a given CpG across the time course we multiplied all probabilities obtained at 0, 4, 8, 10, 13, 17, and 29 days. Each biological replicate was fit separately in this manner. Having performed this calculation for all possible parameter combinations, we then used Bayes’ theorem to calculate the probability of the parameters given the data p(parameters|data) assuming a uniform prior. We did so by renormalizing the probabilities obtained from the calculation of p(data|parameters) to a total of 1. As optimal parameters for kde and kme, we used the maximum likelihood solution that we extracted from p(parameters|data). To determine credible intervals for kde and kme, we first calculated the respective marginal probability density functions p(kde|data) and p(kme|data) and then determined the range that covered 95% of the area under the curve. Replicates were combined by calculating the median for all rates as well as the standard errors for the credible intervals (ci = sqrt(ci12 + ci22 + ci32)/3). We additionally used our inference procedure to identify CpGs for which rates could not be determined. This occurred when the probability density functions p(kde|data) or p(km|data) showed substantial above zero densities at the borders of our parameter space, indicating that the optimal parameters lied outside of our parameter space. We thus considered CpGs identifiable only if they showed <0.08 probability at any border for all the replicates.
Comparison of wild-type and TTKO rates
To determine if de novo methylation and passive demethylation rates are affected by TET activity, we conducted time-course experiments and amplicon bisulfite sequencing using the parental line with TET1/2/3 activity. This assay was otherwise identical to that performed in the TTKO line using amplicon bisulfite sequencing. While inspecting the methylation traces over the time course, we noticed a subtle difference between wild-type and TTKO lines in the mock treatment. While methylation measurements in the TTKO mock time course remained stable, there was a slight increase in methylation between days 4 and 8 measured in the wild-type mock treatment (Supplementary Fig. 4d). This effect was also present in Cre-treated samples, suggesting a secondary effect of the transduction protocol independent of Cre activity.
To systematically account for this, we normalized the Cre-treated time-course measurements to the corresponding mock-treated samples. This was done through creating a baseline for each CpG in the Cre-treated samples. These baselines were established by first binning CpGs at day 0 in increments of 10% (ten bins total) and calculating the average methylation level at each time point within the bin. The binning allows for more a more robust baseline estimation because we are averaging many CpGs around a similar steady state. We then divided each point in the baseline by the measurement at day 0 for the respective bin. These correction factors were used on the corresponding Cre-treated samples by multiplying every value in the time course by the respective baseline adjusted value. Applying this correction resulted in traces closely resembling the dynamics seen in the TTKO amplicon time course (compare Supplementary Fig. 4d and Fig. 1f). After normalizing the Cre-treated samples, we inferred the kde for the wild-type time course kdeWT in an identical manner to that described for the TTKO amplicon time course.
If TET activity does not effect de novo methylation and passive demethylation rates, we should be able to predict the demethylation rate in wild type using only steady-state measurements in both cell lines. Our model explicitly describes the relationship between demethylation rate and steady-state levels, and this relationship is mathematically derived in Supplementary Fig. 4c. Using this equation, we estimated the demethylation rate in wild type, namely kdeWT^, for 405 CpGs using only steady-state methylation levels in the two genetic backgrounds. We then compared kdeWT^ to rates inferred using the whole time course kdeWT, as described above (Supplementary Fig. 4e). For the 155 CpGs, whereby we could estimate and infer demethylation rate robustly, our estimates accurately recapitulate methylation dynamics in the wild-type setting and these predictions are significantly more accurate than comparing kdeWT and kdeTTKO directly (Supplementary Fig. 2f).
To rule out the possibility that our estimations are a result of the mock normalization procedure described above, we inferred rates in the wild-type time course in the absence of normalization. Importantly, our rate predictions were unaffected by this normalization procedure, highlighting the robustness of our model and rate inference strategy (Supplementary Fig. 2e–h).
Inference of SureSelect methylation/demethylation rates
Methylation and demethylation rates were inferred the same way as for the amplicon bisulfite data using a binomial distribution for the error model instead of a beta-binomial. Due to the lower coverage of the SureSelect data, the beta-binomial was not necessary. A simple binomial error model performed well in capturing the variability observed between replicate experiments (Supplementary Fig. 3b).
Calculation of the identifiable landscape
To determine the identifiable parameter space, we performed parameter inference on the 6400 simulated methylation traces for which kde and kme are known. Using our inference procedure described above, we then asked to what degree all parameters can be recovered. In the beta-binomial error model, we set n to the median coverage observed in the amplicon data (n = 3997). By calculating credible intervals for all parameter combinations, we were able to visualize the identifiable landscape. Because our experiments consisted of three biological replicates, we calculated standard errors of the credible intervals with n = 3 before plotting the heatmap. We identified parameter combinations that could not be determined as stated above considering a maximum of 0.05 probability at the border of the probability density functions for p(kde|data) and p(kme|data).
ChIP-seq data processing
The following published ChIP datasets were used in this study (GEO accessions): ADNP (GSM2582357), CTCF (ref. 5; GSM747535); KLF4, SOX2, NANOG, and OCT4 (ref. 111; GSM2417188, GSM2417144, GSM2417143, GSM2417187, and GSM2417142); NRF1 (ref. 103; GSM1891642); p53 (ref. 112; GSM647224); PRDM14 (ref. 113; GSM623989), REST (ref. 114; GSM671095); TCFCP2I1, ESRRB, and ZFX (ref. 64; GSM288350, GSM288355, and GSM288352); and MAFK and ZC3H11A (ref. 115; GSM1003809, GSM1003810).
Datasets were downloaded from GEO using the SRAdb R package116 and aligned to the mm10 assembly of the mouse genome using Bowtie117 within the QuasR118 package. Bowtie was run using QuasR default parameters, returning only unique alignments. For each sample, the average fragment length was inferred directly from the data. This was done by determining the most frequent distance between the 5′ end of plus and minus strand reads on chromosome 1 with a distance interval spanning (read length +20) up to 500 bp. The lower limit of this interval was set significantly larger than the read length due to a second peak in the distance histogram at the exact read length in some samples, likely caused by a mapping artifact. The distance between pairs of reads with identical 5′ positions were counted only once to reduce potential amplification biases. All read counting in given genomic regions was done using the QuasR function qCount, whereby reads were shifted by half the estimated average fragment length determined above. For all replicates across TF datasets, peaks were identified using MACS2119 under default parameters and with corresponding control samples as a background. Resulting peaks were then filtered requiring at least 80% mappability. Here, we define mappability as the fraction of all possible 25mers in a given region that are uniquely mappable using the alignment parameters above. Because the percentage of mappable bases in the genome changes in a minor way when increasing the read length under the given alignment parameters (74.9% for 25mers, 80% for 36mers, and 83.3% for 50mers, while 51 is the longest read length in the dataset), we do not believe that this choice of read length to define mappability has a significant effect on the presented results. The library-size normalized counts were determined as:
nsIP = min(NIP, Ncontrol) × (nIP/NIP) and nscontrol = min(NIP, Ncontrol) × (ncontrol/Ncontrol)
Where nIP and ncontrol are the raw counts per peak, and NIP and Ncontrol are the total number of reads mapping to the genome in the IP and control sample, respectively. Thus counts were in each case scaled down to the smaller library size. For each dataset, enrichment over input in peaks was defined as log2(nsIP + 8) − log2(nscontrol + 8), using a pseudo-count of 8 to decrease noise levels in case of low read counts. Only peaks with a log2 enrichment of at least 1 were retained for further analysis. The 500 top-enriched peaks (or all peaks if there were fewer than 500 peaks) were used for de novo motif finding using HOMER120. HOMER was run using the function findMotifsGenome.pl using six different motif lengths (6, 10, 14, 18, and 22) and 200nt long sequences centered on each peak as input. For each dataset, the top-enriched motif was retained. The start or end positions of weight matrices were trimmed in cases where at least four consecutive positions had very low information content. The resulting weight matrices were compared to entries for the corresponding factors in either the HOMER database, the Jaspar database121 the Encode factor book (for the datasets from Mouse ENCODE, www.factorbook.org) or the original publications to confirm similarity to the previously inferred weight matrices for each corresponding factor. In cases where replicate ChIP experiments produced matrices in the opposite orientation, matrices were reverse complemented so they all had the same orientation. Each inferred weight matrix was then used to scan the genome using the matchPWM function from Biostrings R package122. Matching sequences were determined by requiring a log2(odds) score of at least 10 (in log2 scale) over a uniform background. In cases where two (or multiple) matches overlapped (ignoring their strands), only the match with the highest log(odds) score was retained. This is frequently the case for palindromic or nearly palindromic weight matrices, which often generate a match to both strands. Finally, for each dataset, log2 enrichments at the predicted sites were calculated by counting reads in a 201 bp window centered at the midpoint of each motif. In cases of multiple replicates for a given TF, we selected the replicate with the largest number of enriched motif-centered regions (which corresponds to the GEO accession above), after ensuring that all replicates showed similar patterns.
Replication timing data
Data for replication timing in murine ESCs was downloaded in processed form from the ENCODE consortium115. The specific accessions used in this work are ENCFF001JUP and ENCFF001JUQ.
Further information on research design is available in the Nature Research Reporting Summary linked to this article.
Raw and processed sequencing data has been deposited in the Gene Expression Omnibus (GEO) database under the accession number GSE129470. All publicly available data sets used are referenced in the relevant methods section. All other relevant data supporting the key findings of this study are available within the article and its Supplementary Information files or from the corresponding author upon reasonable request. The source data underlying Fig. 3b and Supplementary Fig. 1e–h are provided as a Source data file. A reporting summary for this article is available as a Supplementary Information file.
Data analysis and graphical representation was performed using custom R scripts and publicly available packages as denoted in the text. All scripts are available upon request.
Baubec, T. & Schubeler, D. Genomic patterns and context specific interpretation of DNA methylation. Curr. Opin. Genet Dev. 25, 85–92 (2014).
Jaenisch, R. & Bird, A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat. Genet. 33, 245–254 (2003).
Bird, A. DNA methylation patterns and epigenetic memory. Genes Dev. 16, 6–21 (2002).
Smith, Z. D. & Meissner, A. DNA methylation: roles in mammalian development. Nat. Rev. Genet. 14, 204–220 (2013).
Stadler, M. B. et al. DNA-binding factors shape the mouse methylome at distal regulatory regions. Nature 480, 490–495 (2011).
Lister, R. et al. Human DNA methylomes at base resolution show widespread epigenomic differences. Nature 462, 315–322 (2009).
Okano, M., Xie, S. & Li, E. Cloning and characterization of a family of novel mammalian DNA (cytosine-5) methyltransferases. Nat. Genet. 19, 219–220 (1998).
Okano, M., Bell, D. W., Haber, D. A. & Li, E. DNA methyltransferases Dnmt3a and Dnmt3b are essential for de novo methylation and mammalian development. Cell 99, 247–257 (1999).
Hermann, A., Goyal, R. & Jeltsch, A. The Dnmt1 DNA-(cytosine-C5)-methyltransferase methylates DNA processively with high preference for hemimethylated target sites. J. Biol. Chem. 279, 48350–48359 (2004).
Goll, M. G. & Bestor, T. H. Eukaryotic cytosine methyltransferases. Annu Rev. Biochem 74, 481–514 (2005).
Li, E., Bestor, T. H. & Jaenisch, R. Targeted mutation of the DNA methyltransferase gene results in embryonic lethality. Cell 69, 915–926 (1992).
Kagiwada, S., Kurimoto, K., Hirota, T., Yamaji, M. & Saitou, M. Replication-coupled passive DNA demethylation for the erasure of genome imprints in mice. EMBO J. 32, 340–353 (2013).
Tahiliani, M. et al. Conversion of 5-methylcytosine to 5-hydroxymethylcytosine in mammalian DNA by MLL partner TET1. Science 324, 930–935 (2009).
Hackett, J. A. et al. Germline DNA demethylation dynamics and imprint erasure through 5-hydroxymethylcytosine. Science 339, 448–452 (2013).
Yamaguchi, S. et al. Dynamics of 5-methylcytosine and 5-hydroxymethylcytosine during germ cell reprogramming. Cell Res. 23, 329–339 (2013).
Seisenberger, S. et al. The dynamics of genome-wide DNA methylation reprogramming in mouse primordial germ cells. Mol. Cell 48, 849–862 (2012).
Ito, S. et al. Role of Tet proteins in 5mC to 5hmC conversion, ES-cell self-renewal and inner cell mass specification. Nature 466, 1129–1133 (2010).
Hon, G. C. et al. 5mC oxidation by Tet2 modulates enhancer activity and timing of transcriptome reprogramming during differentiation. Mol. Cell 56, 286–297 (2014).
Ito, S. et al. Tet proteins can convert 5-methylcytosine to 5-formylcytosine and 5-carboxylcytosine. Science 333, 1300–1303 (2011).
He, Y. F. et al. Tet-mediated formation of 5-carboxylcytosine and its excision by TDG in mammalian DNA. Science 333, 1303–1307 (2011).
Pfaffeneder, T. et al. The discovery of 5-formylcytosine in embryonic stem cell DNA. Angew. Chem. Int. Ed. Engl. 50, 7008–7012 (2011).
Dawlaty, M. M. et al. Tet1 is dispensable for maintaining pluripotency and its loss is compatible with embryonic and postnatal development. Cell Stem Cell 9, 166–175 (2011).
Dawlaty, M. M. et al. Combined deficiency of Tet1 and Tet2 causes epigenetic abnormalities but is compatible with postnatal development. Dev. Cell 24, 310–323 (2013).
Koh, K. P. et al. Tet1 and Tet2 regulate 5-hydroxymethylcytosine production and cell lineage specification in mouse embryonic stem cells. Cell Stem Cell 8, 200–213 (2011).
Gu, T. P. et al. The role of Tet3 DNA dioxygenase in epigenetic reprogramming by oocytes. Nature 477, 606–610 (2011).
Li, Z. et al. Deletion of Tet2 in mice leads to dysregulated hematopoietic stem cells and subsequent development of myeloid malignancies. Blood 118, 4509–4518 (2011).
Dawlaty, M. M. et al. Loss of Tet enzymes compromises proper differentiation of embryonic stem cells. Dev. Cell 29, 102–111 (2014).
Chen, T., Ueda, Y., Dodge, J. E., Wang, Z. & Li, E. Establishment and maintenance of genomic methylation patterns in mouse embryonic stem cells by Dnmt3a and Dnmt3b. Mol. Cell. Biol. 23, 5594–5605 (2003).
Li, Y. et al. Stella safeguards the oocyte methylome by preventing de novo methylation mediated by DNMT1. Nature 564, 136–140 (2018).
Chuang, L. S. et al. Human DNA-(cytosine-5) methyltransferase-PCNA complex as a target for p21WAF1. Science 277, 1996–2000 (1997).
Lei, H. et al. De novo DNA cytosine methyltransferase activities in mouse embryonic stem cells. Development 122, 3195–3205 (1996).
Song, J., Rechkoblit, O., Bestor, T. H. & Patel, D. J. Structure of DNMT1-DNA complex reveals a role for autoinhibition in maintenance DNA methylation. Science 331, 1036–1040 (2011).
Vilkaitis, G., Suetake, I., Klimasauskas, S. & Tajima, S. Processive methylation of hemimethylated CpG sites by mouse Dnmt1 DNA methyltransferase. J. Biol. Chem. 280, 64–72 (2005).
Arand, J. et al. In vivo control of CpG and non-CpG DNA methylation by DNA methyltransferases. PLoS Genet. 8, e1002750 (2012).
Gowher, H. & Jeltsch, A. Enzymatic properties of recombinant Dnmt3a DNA methyltransferase from mouse: the enzyme modifies DNA in a non-processive manner and also methylates non-CpG [correction of non-CpA] sites. J. Mol. Biol. 309, 1201–1208 (2001).
von Meyenn, F. et al. Impairment of DNA Methylation Maintenance Is the Main Cause of Global Demethylation in Naive Embryonic Stem Cells. Mol. Cell 62, 848–861 (2016).
Genereux, D. P., Miner, B. E., Bergstrom, C. T. & Laird, C. D. A population-epigenetic model to infer site-specific methylation rates from double-stranded DNA methylation patterns. Proc. Natl Acad. Sci. USA 102, 5802–5807 (2005).
Fu, A. Q. et al. Statistical inference of in vivo properties of human DNA methyltransferases from double-stranded methylation patterns. PloS ONE 7, e32225 (2012).
Sontag, L. B., Lorincz, M. C. & Georg Luebeck, E. Dynamics, stability and inheritance of somatic DNA methylation imprints. J. Theor. Biol. 242, 890–899 (2006).
Choi, M. et al. Epigenetic memory via concordant DNA methylation is inversely correlated to developmental potential of mammalian cells. PLoS Genet. 13, e1007060 (2017).
Jeltsch, A. & Jurkowska, R. Z. New concepts in DNA methylation. Trends Biochem. Sci. 39, 310–318 (2014).
Rulands, S. et al. Genome-scale oscillations in DNA methylation during exit from pluripotency. Cell Syst. 7, e12 (2018).
Pfeifer, G. P., Steigerwald, S. D., Hansen, R. S., Gartler, S. M. & Riggs, A. D. Polymerase chain reaction-aided genomic sequencing of an X chromosome-linked CpG island: methylation patterns suggest clonal inheritance, CpG site autonomy, and an explanation of activity state stability. Proc. Natl Acad. Sci. USA 87, 8252–8256 (1990).
Wang, H. et al. One-step generation of mice carrying mutations in multiple genes by CRISPR/Cas-mediated genome engineering. Cell 153, 910–918 (2013).
Dodge, J. E. et al. Inactivation of Dnmt3b in mouse embryonic fibroblasts results in DNA hypomethylation, chromosomal instability, and spontaneous immortalization. J. Biol. Chem. 280, 17986–17991 (2005).
Kaneda, M. et al. Essential role for de novo DNA methyltransferase Dnmt3a in paternal and maternal imprinting. Nature 429, 900–903 (2004).
Munst, B., Patsch, C. & Edenhofer, F. Engineering cell-permeable protein. J. Vis. Exp. https://doi.org/10.3791/1627 (2009).
Schwanhausser, B. et al. Global quantification of mammalian gene expression control. Nature 473, 337–342 (2011).
Tamm, C., Pijuan Galito, S. & Anneren, C. A comparative study of protocols for mouse embryonic stem cell culturing. PloS ONE 8, e81156 (2013).
Burger, L., Gaidatzis, D., Schubeler, D. & Stadler, M. B. Identification of active regulatory regions from DNA methylation data. Nucleic Acids Res. 41, e155 (2013).
Hiratani, I., Takebayashi, S., Lu, J. & Gilbert, D. M. Replication timing and transcriptional control: beyond cause and effect–part II. Curr. Opin. Genet Dev. 19, 142–149 (2009).
Ernst, J. & Kellis, M. Chromatin-state discovery and genome annotation with ChromHMM. Nat. Protoc. 12, 2478–2492 (2017).
Ernst, J. & Kellis, M. Discovery and characterization of chromatin states for systematic annotation of the human genome. Nat. Biotechnol. 28, 817–825 (2010).
Pintacuda, G. et al. hnRNPK recruits PCGF3/5-PRC1 to the Xist RNA B-repeat to establish polycomb-mediated chromosomal silencing. Mol. Cell 68, e910 (2017).
Baubec, T. et al. Genomic profiling of DNA methyltransferases reveals a role for DNMT3B in genic methylation. Nature 520, 243–247 (2015).
Neri, F. et al. Intragenic DNA methylation prevents spurious transcription initiation. Nature 543, 72–77 (2017).
Goldberg, A. D. et al. Distinct factors control histone variant H3.3 localization at specific genomic regions. Cell 140, 678–691 (2010).
Wirbelauer, C., Bell, O. & Schubeler, D. Variant histone H3.3 is deposited at sites of nucleosomal displacement throughout transcribed genes while active histone modifications show a promoter-proximal bias. Genes Dev. 19, 1761–1766 (2005).
Rothbart, S. B. et al. Association of UHRF1 with methylated H3K9 directs the maintenance of DNA methylation. Nat. Struct. Mol. Biol. 19, 1155–1160 (2012).
Sharif, J. et al. The SRA protein Np95 mediates epigenetic inheritance by recruiting Dnmt1 to methylated DNA. Nature 450, 908–912 (2007).
Bostick, M. et al. UHRF1 plays a role in maintaining DNA methylation in mammalian cells. Science 317, 1760–1764 (2007).
Doi, A. et al. Differential methylation of tissue- and cancer-specific CpG island shores distinguishes human induced pluripotent stem cells, embryonic stem cells and fibroblasts. Nat. Genet. 41, 1350–1353 (2009).
Manzo, M. et al. Isoform-specific localization of DNMT3A regulates DNA methylation fidelity at bivalent CpG islands. EMBO J. 36, 3421–3434 (2017).
Chen, X. et al. Integration of external signaling pathways with the core transcriptional network in embryonic stem cells. Cell 133, 1106–1117 (2008).
Fu, Y., Sinha, M., Peterson, C. L. & Weng, Z. The insulator binding protein CTCF positions 20 nucleosomes around its binding sites across the human genome. PLoS Genet. 4, e1000138 (2008).
Valouev, A. et al. Determinants of nucleosome organization in primary human cells. Nature 474, 516–520 (2011).
Adachi, K. et al. Esrrb unlocks silenced enhancers for reprogramming to naive pluripotency. Cell Stem Cell 23, e266, https://doi.org/10.1016/j.stem.2018.05.020 (2018).
Iurlaro, M. et al. A screen for hydroxymethylcytosine and formylcytosine binding proteins suggests functions in transcription and chromatin regulation. Genome Biol. 14, R119 (2013).
Barisic, D., Stadler, M. B., Iurlaro, M. & Schubeler, D. Mammalian ISWI and SWI/SNF selectively mediate binding of distinct transcription factors. Nature 569, 136–140 (2019).
Ooi, S. K. et al. DNMT3L connects unmethylated lysine 4 of histone H3 to de novo methylation of DNA. Nature 448, 714–717 (2007).
Otani, J. et al. Structural basis for recognition of H3K4 methylation status by the DNA methyltransferase 3A ATRX-DNMT3-DNMT3L domain. EMBO Rep. 10, 1235–1241 (2009).
Dhayalan, A. et al. The Dnmt3a PWWP domain reads histone 3 lysine 36 trimethylation and guides DNA methylation. J. Biol. Chem. 285, 26114–26120 (2010).
Keogh, M. C. et al. Cotranscriptional set2 methylation of histone H3 lysine 36 recruits a repressive Rpd3 complex. Cell 123, 593–605 (2005).
Krogan, N. J. et al. Methylation of histone H3 by Set2 in Saccharomyces cerevisiae is linked to transcriptional elongation by RNA polymerase II. Mol. Cell. Biol. 23, 4207–4218 (2003).
Zemach, A. & Zilberman, D. Evolution of eukaryotic DNA methylation and the pursuit of safer sex. Curr. Biol. 20, R780–785 (2010).
Zilberman, D. An evolutionary case for functional gene body methylation in plants and animals. Genome Biol. 18, 87 (2017).
Kim, M. Y. & Zilberman, D. DNA methylation as a system of plant genomic immunity. Trends Plant Sci. 19, 320–326 (2014).
Bewick, A. J. & Schmitz, R. J. Gene body DNA methylation in plants. Curr. Opin. Plant Biol. 36, 103–110 (2017).
Rodrigues, J. A. & Zilberman, D. Evolution and function of genomic imprinting in plants. Genes Dev. 29, 2517–2531 (2015).
Xie, S., Jakoncic, J. & Qian, C. UHRF1 double tudor domain and the adjacent PHD finger act together to recognize K9me3-containing histone H3 tail. J. Mol. Biol. 415, 318–328 (2012).
Arita, K. et al. Recognition of modification status on a histone H3 tail by linked histone reader modules of the epigenetic regulator UHRF1. Proc. Natl Acad. Sci. USA 109, 12950–12955 (2012).
Cheng, J. et al. Structural insight into coordinated recognition of trimethylated histone H3 lysine 9 (H3K9me3) by the plant homeodomain (PHD) and tandem tudor domain (TTD) of UHRF1 (ubiquitin-like, containing PHD and RING finger domains, 1) protein. J. Biol. Chem. 288, 1329–1339 (2013).
Liu, X. et al. UHRF1 targets DNMT1 for DNA methylation through cooperative binding of hemi-methylated DNA and methylated H3K9. Nat. Commun. 4, 1563 (2013).
Yin, Y. et al. Impact of cytosine methylation on DNA binding specificities of human transcription factors. Science 356, 1–15 (2017).
Kribelbauer, J. F. et al. Quantitative analysis of the DNA methylation sensitivity of transcription factor complexes. Cell Rep. 19, 2383–2395 (2017).
Zuo, Z., Roy, B., Chang, Y. K., Granas, D. & Stormo, G. D. Measuring quantitative effects of methylation on transcription factor-DNA binding affinity. Sci. Adv. 3, eaao1799 (2017).
Wu, H. & Zhang, Y. Reversing DNA methylation: mechanisms, genomics, and biological functions. Cell 156, 45–68 (2014).
Lu, F., Liu, Y., Jiang, L., Yamaguchi, S. & Zhang, Y. Role of Tet proteins in enhancer activity and telomere elongation. Genes Dev. 28, 2103–2119 (2014).
Feldmann, A. et al. Transcription factor occupancy can mediate active turnover of DNA methylation at regulatory regions. PLoS Genet. 9, e1003994 (2013).
Serandour, A. A. et al. Dynamic hydroxymethylation of deoxyribonucleic acid marks differentiation-associated enhancers. Nucleic Acids Res. 40, 8255–8265 (2012).
Shen, L. et al. Genome-wide analysis reveals TET- and TDG-dependent 5-methylcytosine oxidation dynamics. Cell 153, 692–706 (2013).
Song, C. X. et al. Genome-wide profiling of 5-formylcytosine reveals its roles in epigenetic priming. Cell 153, 678–691 (2013).
Wu, X., Inoue, A., Suzuki, T. & Zhang, Y. Simultaneous mapping of active DNA demethylation and sister chromatid exchange in single cells. Genes Dev. 31, 511–523 (2017).
Zeng, Y. et al. Lin28A binds active promoters and recruits Tet1 to regulate gene expression. Mol. Cell 61, 153–160 (2016).
Guilhamon, P. et al. Meta-analysis of IDH-mutant cancers identifies EBF1 as an interaction partner for TET2. Nat. Commun. 4, 2166, https://doi.org/10.1038/ncomms3166 (2013).
Rampal, R. et al. DNA hydroxymethylation profiling reveals that WT1 mutations result in loss of TET2 function in acute myeloid leukemia. Cell Rep. 9, 1841–1855 (2014).
Xiong, J. et al. Cooperative action between SALL4A and TET proteins in stepwise oxidation of 5-methylcytosine. Mol. Cell 64, 913–925 (2016).
Zhang, H. et al. TET1 is a DNA-binding protein that modulates DNA methylation and gene transcription via hydroxylation of 5-methylcytosine. Cell Res. 20, 1390–1393 (2010).
Xu, Y. et al. Genome-wide regulation of 5hmC, 5mC, and gene expression by Tet1 hydroxylase in mouse embryonic stem cells. Mol. Cell 42, 451–464 (2011).
Xu, Y. et al. Tet3 CXXC domain and dioxygenase activity cooperatively regulate key genes for Xenopus eye and neural development. Cell 151, 1200–1213 (2012).
Ko, M. et al. Modulation of TET2 expression and 5-methylcytosine oxidation by the CXXC domain protein IDAX. Nature 497, 122–126 (2013).
Charlton, J. et al. Global delay in nascent strand DNA methylation. Nat. Struct. Mol. Biol. 25, 327–332 (2018).
Domcke, S. et al. Competition between DNA methylation and transcription factors determines binding of NRF1. Nature 528, 575–579 (2015).
Hawkes, R., Niday, E. & Gordon, J. A dot-immunobinding assay for monoclonal and other antibodies. Anal. Biochem. 119, 142–147 (1982).
Bibel, M., Richter, J., Lacroix, E. & Barde, Y. A. Generation of a defined and uniform population of CNS progenitors and neurons from mouse embryonic stem cells. Nat. Protoc. 2, 1034–1043 (2007).
Haupt, S., Edenhofer, F., Peitz, M., Leinhaas, A. & Brustle, O. Stage-specific conditional mutagenesis in mouse embryonic stem cell-derived neural cells and postmitotic neurons by direct delivery of biologically active Cre recombinase. Stem Cells 25, 181–188 (2007).
Pfaffl, M. W. A new mathematical model for relative quantification in real-time RT-PCR. Nucleic Acids Res. 29, e45 (2001).
Akalin, A. AmpliconBiSeq: analyzing amplicon bisulfite sequencing data. R package version 0.1.17 https://github.com/BIMSBbioinfo/AmpliconBiSeq (2014).
Soetaert, K., Petzoldt, T. & Setzer, R. W. Solving differential equations in R: package deSolve. J. Stat. Softw. 33, 1–25 (2010).
Dolzhenko, E. & Smith, A. D. Using beta-binomial regression for high-precision differential methylation analysis in multifactor whole-genome bisulfite sequencing experiments. BMC Bioinform. 15, 215 (2014).
Chronis, C. et al. Cooperative binding of transcription factors orchestrates reprogramming. Cell 168, e420 (2017).
Li, M. et al. Distinct regulatory mechanisms and functions for p53-activated and p53-repressed DNA damage response genes in embryonic stem cells. Mol. Cell 46, 30–42 (2012).
Ma, Z., Swigut, T., Valouev, A., Rada-Iglesias, A. & Wysocka, J. Sequence-specific regulator Prdm14 safeguards mouse ESCs from entering extraembryonic endoderm fates. Nat. Struct. Mol. Biol. 18, 120–127 (2011).
Arnold, P. et al. Modeling of epigenome dynamics identifies transcription factors that mediate Polycomb targeting. Genome Res. 23, 60–73 (2013).
Consortium, E. P. An integrated encyclopedia of DNA elements in the human genome. Nature 489, 57–74 (2012).
Zhu, Y., Stephens, R. M., Meltzer, P. S. & Davis, S. R. SRAdb: query and use public next-generation sequencing data from within R. BMC Bioinform. 14, 19 (2013).
Langmead, B., Trapnell, C., Pop, M. & Salzberg, S. L. Ultrafast and memory-efficient alignment of short DNA sequences to the human genome. Genome Biol. 10, R25 (2009).
Gaidatzis, D., Lerch, A., Hahne, F. & Stadler, M. B. QuasR: quantification and annotation of short reads in R. Bioinformatics 31, 1130–1132 (2015).
Zhang, Y. et al. Model-based analysis of ChIP-Seq (MACS). Genome Biol. 9, R137 (2008).
Heinz, S. et al. Simple combinations of lineage-determining transcription factors prime cis-regulatory elements required for macrophage and B cell identities. Mol. Cell 38, 576–589 (2010).
Khan, A. et al. JASPAR 2018: update of the open-access database of transcription factor binding profiles and its web framework. Nucleic Acids Res. 46, D260–D266 (2018).
Pagès H., Aboyoun P., Gentleman R., & DebRoy S. Biostrings: efficient manipulation of biological strings. R package version 2.50.2 (2019).
We thankfully acknowledge En Li and Hiroyuki Sasaki for sharing the Dnmt3a and Dnmt3b floxed conditionally deficient mouse strains. We thank Matthew Lorincz, Michael Stadler, Mario Iurlaro, and members of the Schübeler group for feedback on project and manuscript. Research in the laboratory of D.S. and A.H.F.M.P. are supported by the Novartis Research Foundation, the European Research Council (ERC) under the European Union’s Horizon research and innovation program (Grant agreement no. 667951—ReaDMe to D.S and ERC 695288—Totipotency to A.H.F.M.P.). D.S. acknowledges support by the Swiss National Sciences Foundation. A.K acknowledges support by a Swiss National Fund Ambizione grant (PZOOP3_161493). A.F. acknowledges support by the Marie-Curie Training Network “Nucleosome 4D”.
The authors declare no competing interests.
Peer review information Nature Communications thanks Maxim Greenberg, Wolf Reik and the other, anonymous, reviewer(s) for their contribution to the peer review of this work. Peer reviewer reports are available.
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Ginno, P.A., Gaidatzis, D., Feldmann, A. et al. A genome-scale map of DNA methylation turnover identifies site-specific dependencies of DNMT and TET activity. Nat Commun 11, 2680 (2020). https://doi.org/10.1038/s41467-020-16354-x
Nature Reviews Genetics (2021)
Nature Reviews Genetics (2021)
B1a and B2 cells are characterized by distinct CpG modification states at DNMT3A-maintained enhancers
Nature Communications (2021)
Nature Genetics (2021)